UPDATE: Alexion Completes Rolling BLA Submission to U.S. FDA for Asfotase Alfa

By: via Benzinga
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today completion of the rolling submission of a Biologics License Application ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.